期刊文献+

有限稀释法分选人骨肉瘤143-B干细胞及鉴定

A method of limited dilution to sort human osteosarcoma 143-B stem cells and its identification
原文传递
导出
摘要 目的:探索人骨肉瘤143-B干细胞的分选及鉴定方法。方法:采用有限稀释法对143-B细胞进行干细胞的分选,并检测所获取细胞表面干细胞标志物Nanog和OCT4的表达水平;对所获取的细胞进行成骨及成脂诱导分化,以检测其是否具有多向分化的潜能;动物成瘤实验鉴定细胞的成瘤能力,耐药实验检测顺铂对细胞半数抑制浓度(half inhibitory concentration,IC50)的影响。结果:分选获得的单克隆143-L细胞具有较高的成球能力;143-L细胞表面Nanog和OCT4 m RNA和蛋白的表达水平均明显高于亲代143-B细胞;对其进行成骨及成脂多向诱导分化成功。143-L细胞的成瘤能力及耐药能力(顺铂对143-B及143-L细胞的IC50值分别为0.83和2.51μg/m L)均明显高于143-B细胞。结论:有限稀释法可以用于143-B细胞干细胞的分选。 Objective:To explore the methods of cell sorting and indentification of human osteosarcoma 143-B stem cells.Methods:The 143-B cells were treated by limited dilution method for stem cell sorting,and the expression levels of Nanog and 0CT4 were determined.The multipotentials of osteogenic and adipogenic differentiation were detected.The ablility of tumorigenesis was examined by tumor formation experiment in vivo,and the drug resistance assay was performed to detect the effect of cisplatin on half inhibitory concentration(IC_(50)).Results:The monoclonal 143-L cells obtained by cell sorting had a high ability of sphere formation.The Nanog and 0CT4 expression levels on obtained monoclonal cells(143-L cells) were significantly higher than those in 143-B cells.Meanwhile,the 143-B cells had multipotentials of osteogenic,adipogenic and chondrogenic differentiation.Furthermore,the tumorigenicity in nude mice and drug resistant ability of143-L cells(the IC_(50)values of 143-B and 143-L cells were 0.83 and 2.51μg/mL,respectively)were stronger than those of 143-B cells.Conclusion:The limited dilution method can be used to sort 143-B stem cells.
出处 《肿瘤》 CAS CSCD 北大核心 2015年第1期16-23,共8页 Tumor
基金 国家自然科学基金资助项目(编号:81271979)~~
关键词 骨肉瘤 肿瘤干细胞 肿瘤干细胞测定 143-B细胞 Osteosarcoma Neoplastic stem cells Tumor stem cell assay 143-B cells
  • 相关文献

参考文献2

二级参考文献42

  • 1Kim CFB, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveo- lar stem cells in normal lung and lung cancer. Cell, 2005, 121(6): 823-835.
  • 2Rawlins EL, Hogan BLM. Epithelial stem cells of the lung: privileged few or opportunities for many? Development, 2006, 133(13): 2455-2465.
  • 3Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 2005, 65(23): 10946-10951.
  • 4Wei)zen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nature Medicine, 2002, 8(9): 979-986.
  • 5Campelo MRG, Curbera GA, Gallego GA, et al. Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clinical & Translational Oncology. 2011, 13(2): 77-83.
  • 6Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumori- genic lung cancer stem cell population. Cell Death Differ, 2008, 15(3): 504-514.
  • 7Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(7): 3983-3988.
  • 8Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tu- morigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 2005, 65 (13): 5506-5511.
  • 9Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res, 2003, 63(18): 5821-5828.
  • 10Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(39): 14228-14233.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部